Yuesai Biotechnology

company

About

Yuesai Biotechnology is a new-generation cell therapy drug developer, focusing on the development of a new generation of cell therapy drugs.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
¥200M
Industries
Biotechnology
Founded date
Jun 1, 2021
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥200M
Yuesai Biotechnology has raised a total of ¥200M in funding over 2 rounds. Their latest funding was raised on Mar 14, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 14, 2022 Seed ¥200M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Yuesai Biotechnology is funded by 1 investors. Ruihua Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Ruihua Venture Capital Seed